DUBLIN, Jan. 14, 2019 /PRNewswire/ --
The "Global Digital Breast Tomosynthesis Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The digital breast tomosynthesis market will register a CAGR of about 13% by 2023.
Breast cancer is the most common malignancy in women globally. Out of all cancers breast cancer accounted for the second-largest number of diagnosed cases. The risk associated with breast cancer are also on the rise. Factors such as high body mass index, poor dietary habits, the lack of physical activity, tobacco use, and alcohol consumption significantly contribute to the rise in cancer incidence. Such factors increase the risk of breast cancer prevalence, which, in turn, increase the demand for DBT, thereby driving the growth of the market.
Growing popularity of D&B
DBT systems offer several advantages compared with standard 2D digital mammography when used alone. These advantages have led many medical practices to adopt DBT before the acquisition of sufficient clinical-effective data. Therefore, key vendors are increasing their R&D investments to incorporate various advanced features in their DBT systems to enhance precision.
Limitations and drawbacks of DBT
DBT is associated with several potentials limitations and practical drawbacks. Some risks of suing DBT may include increased radiation doses, longer scan times, increasing reading times and many more. Such factors likely to hinder the growth.
The global digital breast tomosynthesis market is highly concentrated owing to the presence of a considerable number of players. The vendors in the market are taking strategic initiatives which includes increasing their R&D investments to introduce technologically advanced DBT systems.
This had led the leading vendors which will have high opportunities to capitalize on the needs of the consumers and maximize their revenue. Many international and regional digital breast tomosynthesis companies are vying for their share of the global digital breast tomosynthesis market, and players must differentiate themselves to gain vital traction over their peers.
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market segmentation analysis
PART 04: MARKET SIZING
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Comparison by product
- 2D/3D combination systems
- Standalone 3D systems
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- Key leading countries
- Market opportunity
PART 09: DRIVERS AND CHALLENGES
- Use of computer-aided detection for DBT
- Contrast-enhanced imaging and tomosynthesis image-guided biopsy as emerging applications of DBT
- Increasing focus on developing multimodality imaging systems
PART 10: VENDOR LANDSCAPE
PART 11: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- GE Healthcare
- GMM (IMS GIOTTO)
- PLANMECA (PLANMED)
- Siemens Healthineers
For more information about this report visit https://www.researchandmarkets.com/research/n7fnmd/global_digital?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-digital-breast-tomosynthesis-market-2019-2023---increasing-focus-on-developing-multimodality-imaging-systems-300777491.html
SOURCE Research and Markets